Tolerance induction in rats, using a combination of anti-CD154 and donor splenocytes, given once on the day of transplantation1
- 27 January 2003
- journal article
- Published by Wolters Kluwer Health in Transplantation
- Vol. 75 (2) , 169-172
- https://doi.org/10.1097/01.tp.0000041782.57495.cd
Abstract
Donor-specific tolerance induction remains an attractive objective that generates much research in the field of transplantation. Unfortunately, most of the protocols available involve pregraft conditioning, making these treatments incompatible with clinical applications. LEW.1A rats were grafted with histoincompatible LEW.1W hearts. On the day of transplantation, recipients were treated with anti-CD40L combined with donor splenocytes. The hearts were evaluated for graft survival; cellular infiltrate and intragraft cytokines were determined using real-time reverse transcriptase-polymerase chain reaction. Tolerance induction was assessed by skin grafting and adoptive transfers. The combination of a single injection of anti-CD40L and donor splenocytes, given on the day of surgery, allowed 40% of cardiac allografts to survive long-term (mean survival time=66.3 day). The cellular composition or the extent of graft infiltrate was not modified but was associated with a massive decrease of proinflammatory cytokines expression within the graft. Long-term survivors accepted donor-matched skin grafts, and leukocytes harvested from these animals transferred tolerance into irradiated freshly grafted recipients. A combination of costimulation blockade and donor cells, given once at the time of transplantation, is sufficient to induce allograft tolerance in rats.Keywords
This publication has 17 references indexed in Scilit:
- Direct Recognition of Foreign MHC Determinants by Naive T Cells Mobilizes Specific Vβ Families Without Skewing of the Complementarity-Determining Region 3 Length DistributionThe Journal of Immunology, 2001
- Mechanisms of tolerance induction: blockade of co–stimulationPhilosophical Transactions Of The Royal Society B-Biological Sciences, 2001
- CD40-CD40 Ligand-Independent Activation of CD8+ T Cells Can Trigger Allograft RejectionThe Journal of Immunology, 2000
- Treatment with humanized monoclonal antibody against CD154 prevents acute renal allograft rejection in nonhuman primatesNature Medicine, 1999
- Rat Spleen Dendritic Cells Express Natural Killer Cell Receptor Protein 1 (NKR-P1) and Have Cytotoxic Activity to Select Targets via a Ca2+-dependent MechanismThe Journal of Experimental Medicine, 1997
- PROLONGED SURVIVAL OF MOUSE SKIN ALLOGRAFTS IN RECIPIENTS TREATED WITH DONOR SPLENOCYTES AND ANTIBODY TO CD40 LIGAND1Transplantation, 1997
- Induction of Peripheral T Cell Tolerance In Vivo Requires CTLA-4 EngagementImmunity, 1997
- Costimulatory function and expression of CD40 ligand, CD80, and CD86 in vascularized murine cardiac allograft rejectionProceedings of the National Academy of Sciences, 1996
- CD40-gp39 INTERACTIONS PLAY A CRITICAL ROLE DURING ALLOGRAFT REJECTIONTransplantation, 1996
- CD28-B7 blockade after alloantigenic challenge in vivo inhibits Th1 cytokines but spares Th2.The Journal of Experimental Medicine, 1995